HTC VIVE Technology Used in Penumbra’s REAL Immersive System for Stroke Patient Recovery

REAL™ Immersive System Uses HTC VIVE Focus™ and Animated Content to Provide Rehabilitation to Stroke Patients

REAL™ Immersive System (REAL System) is using a custom-designed VIVE Focus™ head-mounted display to help patients recover from stroke and other neurological injuries.

Penumbra reports evidence shows that rehabilitation can help survivors of neurological injury, such as those due to stroke or trauma, recover their abilities. Rehabilitation drives neuroplasticity, or the brain’s ability to reorganize itself by forming new connections. However, research has shown that only 30% of patients ever attend rehabilitation. And even if they do attend, the average amount of days spent rehabilitating using traditional methods is less than optimum. Created by Penumbra, and using Vive VR technology, the REAL System places patients into an animated world with therapeutic experiences designed to increase neuroplasticity through patient engagement and retention.

“When it comes to patients who have suffered neurological injury, there are very real barriers to overcome in the rehabilitation process,” said Dan O’Brien, HTC Global Head of Enterprise. “We’re excited the Vive Focus can help by providing the power and portability for clinicians to treat patients outside of traditional settings with the REAL System.”

The REAL System is a portable VR rehabilitation solution for upper-extremity rehabilitation that can be used at the patient’s bedside, in a therapy gym, or in a mobile health location. The three main components of the system include the Vive Focus headset, a set of six sensors, and a tablet with the TherapyView™ app that allows the clinician to administer and monitor the therapy session.

Upon powering on, the patient is immediately immersed in VR, engaging in visual and physical challenges guided by their therapist. Body sensors are attached with soft neoprene bands, and in less than two minutes of set-up time, the patient is working in a virtual world with their full-presence avatar. The therapist can see what the patient sees on an included tablet interface, which the therapist uses to select various activities, adjust activity parameters, and monitor the patient’s experience at the tap of a button. Data from the patient’s movement and accomplishments is securely saved so that documentation is easy to produce, and long-term trending can guide the patient’s recovery.

Vive Focus is HTC’s signature standalone headset for enterprises. The high-resolution dual 3K AMOLED screens and Qualcomm® Snapdragon™ 835 processor enables patients to enjoy real-time feedback and interaction with Penumbra’s content, while the wireless headset ensures patients can move freely. Penumbra worked closely with HTC to customize the headset specifically for rehabilitation patients, ensuring that it had the proper weight, fit and comfort.

Hot this week

Medtronic Expands AiBLE Spine Surgery Ecosystem with New Technologies and Siemens Healthineers Partnership

New advancements in the AiBLE Spine Surgery ecosystem build upon the company's commitment to procedural innovation and execution

Axlab, Danish Medtech Pioneer, expands to US with Advanced Robotic Tissue Sectioning for Pathology Laboratories

Kris Rokke, National Sales Director for Axlab in the US. "My team and I are extremely excited and honored about this unique opportunity to also offer this advanced technology to labs across the US and thus contribute to the pathology labs of tomorrow."

Spartan Medical Broadens Single-Use Sterile Instrument Portfolio to Improve Outcomes, Increase Efficiency, and Generate Cost Savings

Spartan Medical products portfolio of single-use, sterile med tech includes micro and minor surgical convenience kits, kerrison rongeurs, spinal and general surgical retractors, dural repair kits, synthetic biologics, and a wide range of orthopedic pre-sterilized implants and devices.

Recor Medical Supports European Society of Cardiology’s Hypertension Guidelines

Record Medical notes the new guidelines, "2024 ESC Guidelines for the management of elevated blood pressure and hypertension," have been published online and recommend the consideration of renal denervation (RDN) as a safe and effective treatment option for patients who have uncontrolled resistant hypertension or those that have uncontrolled hypertension with a higher risk of cardiovascular disease, who express a preference to undergo RDN.

ConTIPI Medical Selects EVERSANA to Support U.S. Commercialization of Non-Surgical Medical Device ProVate for Women with Pelvic Organ Prolapse

EVERSANA is a leading provider of global commercial services to the life sciences industry, to support commercialization for the ProVate device in the United States to help women experiencing pelvic organ prolapse.